Hepion Pharmaceuticals
(NASDAQ:HEPA)
$0.5725
-0.0051[-0.88%]
At close: Jun 30
$0.6076
0.0351[6.13%]
After Hours: 8:18AM EDT
Day High/Low0.57 - 0.61
52 Week High/Low0.58 - 2.17
Open / Close0.61 / 0.57
Float / Outstanding76.1M / 76.2M
Vol / Avg.136.7K / 218.5K
Mkt Cap43.6M
P/E-
50d Avg. Price0.77
Div / Yield-
Payout Ratio-
EPS-0.13
Total Float76.1M

Hepion Pharmaceuticals (NASDAQ:HEPA), Quotes and News Summary

Hepion Pharmaceuticals (NASDAQ: HEPA)

Day High/Low0.57 - 0.61
52 Week High/Low0.58 - 2.17
Open / Close0.61 / 0.57
Float / Outstanding76.1M / 76.2M
Vol / Avg.136.7K / 218.5K
Mkt Cap43.6M
P/E-
50d Avg. Price0.77
Div / Yield-
Payout Ratio-
EPS-0.13
Total Float76.1M
Benzinga - Jun 21, 2022, 12:03PM
load more
Sector: Health Care.Industry: Pharmaceuticals
Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-15
REV
Q1 2022Est.ActualSurprise
EPS-0.090
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Hepion Pharmaceuticals Questions & Answers

Q
How do I buy Hepion Pharmaceuticals (HEPA) stock?
A

You can purchase shares of Hepion Pharmaceuticals (NASDAQ: HEPA) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Hepion Pharmaceuticals's (HEPA) competitors?
Q
What is the target price for Hepion Pharmaceuticals (HEPA) stock?
A

The latest price target for Hepion Pharmaceuticals (NASDAQ: HEPA) was reported by Cantor Fitzgerald on Monday, February 28, 2022. The analyst firm set a price target for 3.50 expecting HEPA to rise to within 12 months (a possible 511.35% upside). 1 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Hepion Pharmaceuticals (HEPA)?
A

The stock price for Hepion Pharmaceuticals (NASDAQ: HEPA) is $0.5725 last updated June 30, 2022, 8:00 PM UTC.

Q
Does Hepion Pharmaceuticals (HEPA) pay a dividend?
A

There are no upcoming dividends for Hepion Pharmaceuticals.

Q
When is Hepion Pharmaceuticals (NASDAQ:HEPA) reporting earnings?
A

Hepion Pharmaceuticals’s Q2 earnings are confirmed for Monday, August 15, 2022.

Q
Is Hepion Pharmaceuticals (HEPA) going to split?
A

There is no upcoming split for Hepion Pharmaceuticals.

Q
What sector and industry does Hepion Pharmaceuticals (HEPA) operate in?
A

Hepion Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.